Professor Richard Cohn
M.B.,B.Ch.(Rand), D.C.H. (S.A.), F.C.P. (S.A.) (PAED), FRACP
Senior Staff Specialist Paediatric Haematologist/Oncologist
Subspecialty Paediatric Neuro-Oncology
Clinical Program Director, Medicine and Diagnostics, Sydney Children’s Hospital Network
Conjoint Professor, School of Women’s and Children’s Health, Faculty of Medicine, UNSW
Professor Cohn is a Senior Paediatric Haematologist and Oncologist in the Kids Cancer Centre and has a senior management role as the Clinical Program Director of Medicine and Diagnostics in the Sydney Children’s Hospital Network. He has a senior teaching and research role as a Conjoint Professor in the School of Women’s and Children’s Health, UNSW Medicine. He is Director of the Long-term Follow-up at the Sydney Children’s Hospital. He is chairman of the Childhood Cancer Survivorship sub-committee of the Australian and New Zealand Children’s Haematology Oncology Group (ANZCHOG) and an Executive Committee member of the Clinical Oncology Society of Australia (COSA) Survivorship Subcommittee. He is an Invited member of the International Committee for Harmonization of Health Screening Guidelines for Childhood Cancer survivors and chairman of its subcommittee for Health Screening Guidelines on ototoxicity.
Professor Cohn has published over 240 peer reviewed papers (145 in last 5 years), in the highest ranking journals including Nature, Nature Genetics, Human Genetics, Lancet Oncology, Journal of Clinical Oncology and JAMA Neurology and 3 book chapters. He is a clinician researcher whose research has changed practice in all domains of paediatric haematology and oncology care, from diagnosis to cure and beyond. In collaboration with basic scientists, he has been an investigator on projects which have improved molecular understanding of disease mechanisms. He is an author on landmark publications on the location of the Fanconi Anaemia complementation group A gene (Nature Genetics) and the Fanconi Anaemia Group C gene (Human Mutation) and the molecular subgroups of Medulloblastoma (Nature 2012 – 166 citations), knowledge which is now used to progress personalized medicine. His clinical research reflects a dedication to evidence-based practices and has substantially contributed nationally and internationally to areas such as treatment safety and efficacy (introduction of an algorithm for reducing time to commencing antibiotics in febrile neutropenic patients), multidisciplinary team development, models of long-term follow-up care of cancer survivors ( with the introduction of the health passport), innovative health service delivery (use of E-Health) and psychosocial issues from diagnosis and cure to long-term survivorship and bereavement. The Behavioural Sciences Unit that he established at Sydney Children’s Hospital and of which he is the Medical Director, is regarded as one of the premier centres in the Southern Hemisphere for paediatric/adolescent psychosocial health research.
Ph: (02) 9382 1730
Fax: (02) 9382 1789